COMP <GO>
LECO vs TMO // REVENUE GROWTH (YOY)
Lincoln Electric Holdings Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: LECO 9
— TMO 6
▲ REVENUE GROWTH (YOY) LEADER: LECO
LAST: $276.92 (-2.62%) • MKT CAP: $15.40B
revenue-growth
5.60%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
revenue-growth
3.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LECO VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LECO | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.20% | 41.00% | -4.80 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 24.50% | 9.30% | +15.20 | LECO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.5x | 30.4x | -11.90 | LECO | /valuation <GO> |
| Free Cash Flow Yield | 3.06% | 2.40% | +0.66 | LECO | /fcf-yield <GO> |
| Operating Margin | 17.00% | 17.40% | -0.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | 12.30% | 15.10% | -2.80 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 5.60% | 3.90% | +1.70 | LECO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.09% | 0.24% | +0.85 | LECO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.61 | 4.50 | +3.11 | LECO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | LECO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.70% | -0.20 | LECO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.8 | 59.1 | -1.34 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 0.94 | -0.05 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.5x | 36.3x | -8.80 | LECO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.40B | $262.22B | -$246.82B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LECO REV | TMO REV | LECO GROSS % | TMO GROSS % | LECO FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.23B | $44.56B | 36.2% | 44.0% | $470.7M | $6.29B |
| FY 2024 | $4.01B | $42.88B | 36.7% | 44.0% | $418.6M | $7.27B |
| FY 2023 | $4.19B | $42.86B | 44.0% | 44.0% | $478.9M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LECO // BETA 0.89
TMO // BETA 0.94